ARKG holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	TXG10x Genomics, Inc. Class A Common Stock	Equity	9.23%	—	2,446,807	US
2	TWSTTwist Bioscience Corporation Common Stock	Equity	8.55%	—	1,153,143	US
3	TEMTempus AI, Inc. Class A Common Stock	Equity	8.30%	—	2,456,823	US
4	CRSPCRISPR Therapeutics AG	Equity	5.25%	—	2,133,972	US
5	ILMNIllumina Inc	Equity	4.78%	—	370,036	US
6	GHGuardant Health, Inc. Common Stock	Equity	4.71%	—	582,585	US
7	NTRANatera, Inc. Common Stock	Equity	4.71%	—	246,976	US
8	ABSIAbsci Corporation Common Stock	Equity	4.62%	—	10,581,097	US
9	CDNACareDx, Inc.	Equity	4.14%	—	1,364,401	US
10	PSNLPersonalis, Inc. Common Stock	Equity	4.01%	—	5,112,135	US
11	LLYEli Lilly & Co.	Equity	3.73%	—	65,296	US
12	VCYTVeracyte, Inc.	Equity	3.30%	—	1,553,681	US
13	BEAMBeam Therapeutics Inc. Common Stock	Equity	3.24%	—	2,696,956	US
14	SDGRSchrodinger, Inc. Common Stock	Equity	2.89%	—	2,245,494	US
15	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	2.84%	—	14,727,265	US
16	CMPSCOMPASS Pathways Plc American Depository Shares	Equity	2.57%	—	4,591,088	US
17	ADPTAdaptive Biotechnologies Corporation Common Stock	Equity	2.32%	—	1,825,333	US
18	NRIXNurix Therapeutics, Inc. Common stock	Equity	2.23%	—	2,060,251	US
19	BFLYButterfly Network, Inc.	Equity	1.92%	—	4,906,762	US
20	NTLAIntellia Therapeutics, Inc	Equity	1.85%	—	3,002,028	US
21	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	1.84%	—	872,018	US
22	ARCTURUS THERAPEUTICS HOLDIN	Equity	1.77%	—	2,819,231	US
23	WGSGeneDx Holdings Corp. Class A Common Stock	Equity	1.70%	—	515,373	US
24	PRMEPrime Medicine, Inc. Common Stock	Equity	1.35%	—	7,727,615	US
25	ALMRAlamar Biosciences, Inc. Common Stock	Equity	1.24%	—	984,456	US
26	PACBPacific Biosciences of California, Inc.	Equity	1.23%	—	10,933,219	US
27	MASS908 Devices Inc. Common Stock	Equity	1.10%	—	1,959,635	US
28	GENBGenerate Biomedicines, Inc. Common Stock	Equity	1.07%	—	1,571,881	US
29	CERSCerus Corp	Equity	0.86%	—	7,687,798	US
30	SCTXScribe Therapeutics Inc. Common Stock	Equity	0.77%	—	824,910	US
31	FRNMFreenome, Inc. Common stock	Equity	0.72%	—	928,888	US
32	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.46%	—	87,165	US
33	QSIQuantum-Si Incorporated Class A Common Stock	Equity	0.41%	—	6,953,474	US
34	GOLDMAN FS TRSY OBLIG INST 468	Equity	0.28%	—	5,823,645	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Decrease	GHGUARDANT HEALTH INC	5.98%	3.49%	−24.8%	Jan 30, 2026 → Apr 30, 2026 SEC
Decrease	TWSTTWIST BIOSCIENCE CORP	7.19%	8.99%	−13.7%	Jan 30, 2026 → Apr 30, 2026 SEC
Increase	CMPSCOMPASS PATHWAYS PLC	1.13%	2.43%	+56.5%	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	AMGNAmgen Inc	1.21%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	ALMRALAMAR BIOSCIENCES INC	—	1.21%	—	Jan 30, 2026 → Apr 30, 2026 SEC
Increase	TEMTEMPUS AI INC	8.25%	9.42%	+21.0%	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	INCYIncyte Corp	1.07%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	BNTXBIONTECH SE	—	1.06%	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	VRTXVertex Pharmaceuticals Inc	0.96%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	LLYELI LILLY & COMPANY	—	0.95%	—	Jan 30, 2026 → Apr 30, 2026 SEC
Decrease	IONSIONIS PHARMACEUTICALS INC	2.61%	1.74%	−27.5%	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	CAICaris Life Sciences Inc	0.74%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Increase	NTLAINTELLIA THERAPEUTICS INC	3.09%	3.82%	+18.2%	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	VEEVVeeva Systems Inc	0.66%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	GENBGENERATE BIOMEDICINES INC	—	0.51%	—	Jan 30, 2026 → Apr 30, 2026 SEC
Increase	ATAIATAIBECKLEY INC	0.97%	1.48%	+34.4%	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	LABStandard BioTools Inc	0.34%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Decrease	BFLYBUTTERFLY NETWORK INC	1.94%	1.89%	−20.6%	Jan 30, 2026 → Apr 30, 2026 SEC
Increase	CERSCERUS CORP	1.23%	1.22%	+12.7%	Jan 30, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.